Purchase Order 75N91025P00391

Award Date 5/16/25
Potential Completion Date 9/15/25
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...
This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...
<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>
<p>This is a firm-fixed price purchase order award by the National Institutes of Health (NIH), National Cancer Institute, to the Medicines and Healthcare Products Regulatory Agency. The award, valued at $55,960.57, is for payment related to a prior award with contract number 75N91020A00003. The period of performance runs through July 23, 2024. This award does not have a set-aside designation.</p>
<p>This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian federal agency, to Abiosciences Inc. for $14,000.00 to provide lab testing services. The award has an ultimate completion date of October 25, 2024 and was made on June 26, 2024. No set-aside designation is mentioned. The contract does not appear to be associated with a larger vehicle.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...
This is a $146,105.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to the Radiation Effects Research Foundation, a non-profit organization, to provide updated cancer incidence data in the atomic bomb survivors in Japan. The contract has no set-aside designation and was awarded on August 1, 2019, with a completion date of July 31, 2021. The data being delivered under this contract supports the NIH's research programs related to the...
<p>This is a $25,000.00 firm fixed price purchase order awarded by the National Cancer Institute, a civilian federal agency, to Chelsea Okoren for the provision of on-call services for the Pediatric Oncology Branch. The period of performance is from July 16, 2024 to March 15, 2025. The contract was not set aside for any small business or socioeconomic program.</p>
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
The National Cancer Institute, a civilian agency within the Department of Health and Human Services, awarded a $20,000.00 firm fixed price purchase order to Nanofcm Co., Ltd., a foreign-owned for-profit manufacturer, for a service agreement to provide a NANOFCM FLOW NANOANALYZER S30. The award does not involve any set-asides and has an ultimate completion date of August 31, 2024. Nanofcm Co., Ltd. is a subsidiary of Nanofcm Inc. and has received multiple prior contract awards from the National...

This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.

Generated 6/24/25, 9:44 AM